Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Telapristone shows promise in preclinical models of breast cancer

Dec. 29, 2010

AKN-028 significantly alters gene expression profiles of AML cells

Dec. 29, 2010

PI3K-alpha inhibitor PIK-75 induces apoptosis of AML cells

Dec. 29, 2010

Interim analysis of SENSE trial data shows superior safety of etravirine vs. efavirenz in HIV

Dec. 29, 2010

ODE-(S)-HPMPA and ODE-(S)-HPMPC inhibit HIV replication by new mode of action

Dec. 29, 2010

Gel formulation of IQP-0528 plus tenofovir evaluated in vitro as HIV therapy

Dec. 28, 2010

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Dec. 28, 2010

In vitro data support potential benefits of TT-30 in complement-mediated diseases

Dec. 28, 2010

Asymmetrical CADA analogue VGD-020 displays improved potency against CD4

Dec. 28, 2010

HDAC inhibitor PCI-24781 displays in vivo anti-inflammatory effects

Dec. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...